Sleeping Aid Market
Sleeping Aid Market Study by Drugs and Devices for Insomnia, Sleep Deprivation, Narcolepsy, and Sleep Apnea from 2024 to 2034
Analysis of Sleeping Aid Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Sleeping Aid Market Outlook (2024 to 2034)
The global sleeping aid market size is projected to reach a valuation of US$ 48.04 billion by the end of 2034, up from US$ 29.88 billion in 2024. Worldwide revenue from the sales of sleeping aids has been projected to increase at 4.9% CAGR from 2024 to 2034.
Sleep disorders affect the sleep cycle or disturb restful sleep, which can lead to daytime tiredness and other symptoms. Persistent sleep disorders result in daytime fatigue despite getting at least seven hours of sleep the night before and a diminished or impaired capacity to engage in routine daytime activities. Insomnia, narcolepsy, restless legs syndrome, and sleep apnea are some of the common sleep disorders.
Lack of sleep can have negative effects on academic and professional performance, interpersonal interactions, thinking, mental health, and weight, and also lead to the onset of diabetes and heart disease. Sleep disorders can be treated with natural sleep remedies using natural or herbal sleeping tablets, and also with homeopathic sleep remedies.
Key Market Growth Drivers
- Production of sleeping aids is increasing in developing countries, thus driving sleeping aid market growth.
- Increasing elderly population and prevalence of obesity are contributing to a rise in sleep problems and fueling demand for sleeping aids.
- Global demand for sleeping aids is driven by the growing patient population with cardiovascular diseases, respiratory issues, and obstructive sleep apnea.
- Treatment options for sleep disturbances encompass psychotherapy, medications, supplements, and wakefulness-promoting pharmaceuticals.
- Sleep apnea devices such as continuous positive airway pressure (CPAP) devices are gaining popularity for treating sleep-related disorders.
- Key sleeping aid manufacturers are introducing a variety of pills, incorporating ingredients like chamomile, hops, L-theanine, and melatonin, to meet the increasing demand.
- Increased awareness of the benefits of adequate sleep is driving demand for sleeping aid products.
- Key sleeping aid market trends that manufacturers are capitalizing on include rising product approvals, government support for improved therapeutic approaches, and advancements in sleep apnea testing.
| Report Attributes | Details |
|---|---|
| Sleeping Aid Market Size (2024E) | US$ 29.88 Billion |
| Forecasted Market Value (2034F) | US$ 48.04 Billion |
| Global Market Growth Rate (2024 to 2034) | 4.9% CAGR |
| North America Market Share (2024E) | 38% |
| East Asia Market Value (2034F) | US$ 8.84 Billion |
| Sales of Sleeping Aid Drugs (2024E) | US$ 5.5 Billion |
| Insomnia Segment Market Value (2034F) | US$ 13.17 Billion |
| Hospitals Segment Market Value (2034F) | US$ 7.02 Billion |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the Opportunities on Offer for Sleeping Aid Manufacturers?
“Increase in Prevalence of Sleep Disorders and Innovation in Healthcare”
Altered sleep patterns brought on by lifestyle changes, easier access to medical services, and an increase in demand for high-quality healthcare are all factors generating opportunities for sleeping aid manufacturers. Several opportunities are opening up for suppliers of sleeping aid devices to address chronic sleep problems and enhance their market share.
Some other factors contributing to the increase in the sleeping aid market size include a focus on the expansion of healthcare infrastructure, widespread use of portable sleep apnea treatment equipment, rising geriatric population, increasing adoption of wearable sensors and monitors, and the pervasive burden of obstructive sleep apnea (OSA) and insomnia.
- May 2019 saw the successful completion of a phase-3 trial for insomnia treatment in patients with mild-to-moderate Alzheimer's disease and dementia using Merck's BELSOMRA (suvorexant) C-IV.
“Rising Awareness of Importance of Quality Sleep for Mental and Physical Well-being”
High quality of life and optimal physical and mental health depend on sufficient sleep. In today's 24/7 culture, inadequate sleep is a common issue with significant negative implications for health. Studies highlight the link between sleep deprivation and both physical and mental well-being.
Insufficient sleep is linked to workplace errors and car accidents, resulting in several injuries and disabilities annually. Adequate sleep is vital for maintaining overall health. Sleep problems elevate an individual's risk of health issues. Consequently, the demand for sleeping aids is on the rise.
Which Factors are Affecting Sales Growth of Sleeping Aids?
“Risk of Side Effects from Sleeping Aids and Wide Availability of Alternative Treatments”
Concerns about the complexity of treating sleep problems are growing with the introduction of new technologies. Furthermore, inadequate equipment standards for sleeping aid machines and insufficient documentation for the use and licensing of sleeping tablets are slowing down market growth. Common adverse reactions to sleeping aids include headaches, prolonged drowsiness, memory and performance issues during the day, and allergic reactions. The availability of alternative medications and treatments like circadian rhythm sleep therapy for conditions like narcolepsy and insomnia presents are also impediments to market growth.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
North America accounts for a sizeable share of the global market for sleeping aids due to the focus of important industry players on innovation as well as rising consumer awareness about sleep quality and sleeping aid products. The market in East Asia is projected to expand at an impressive CAGR of 7.1% through 2034.
Why is the United States a Lucrative Market for Sleeping Aid Producers?
“Growing Awareness of Benefits of Sleeping Aid Products”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 9.62 Billion |
| Growth Rate (2024 to 2034) | 4.2% CAGR |
| Projected Value (2034F) | US$ 14.46 Billion |
The need for relevant sleeping aids is increasing as sleep disorders are becoming more common in the United States. The country is estimated to hold 84.7% sleeping aid market share in North America in 2024. Rising awareness of the benefits of sleeping aids is also contributing to their extensive adoption. The presence of some important market participants such as Merck and Pfizer in the nation is contributing to revenue growth.
Which Trends in China are Sleeping Aid Manufacturers Exploiting?
“Rising Prevalence of Insomnia among Younger Generation”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 1.8 Billion |
| Growth Rate (2024 to 2034) | 7% CAGR |
| Projected Value (2034F) | US$ 3.6 Billion |
The healthcare sector in China is exhibiting significant growth due to several factors such as the increasing number of hospitals equipped with modern facilities, advancements in sleeping aid technology, and the rising prevalence of insomnia among the younger demographic. Lifestyle changes are also playing a pivotal role in driving market expansion. The increasing elderly and obese population in China is projected to boost the demand for sleeping drugs and gadgets.
Category-wise Insights
By product type, revenue from the sales of sleeping aid drugs is estimated at US$ 5.51 billion in 2024. Demand for sleeping aid products for the treatment of insomnia patients is estimated to expand at a 4.8% CAGR from 2024 to 2034
Which Condition Accounts for High Use of Sleeping Aids?
“Increased Demand for Sleeping Aids in Management of Sleep Apnea”
| Attribute | Sleep Apnea |
|---|---|
| Segment Value (2024E) | US$ 8.91 Billion |
| Growth Rate (2024 to 2034) | 5.1% CAGR |
| Projected Value (2034F) | US$ 14.69 Billion |
Sleep apnea is a sleep disorder characterized by irregular breathing patterns during sleep. Chronic sleep apnea results in insufficient oxygen supply to the brain and other organs, leading to irregular breathing during sleep. Elderly individuals and those with conditions like hypertension, diabetes, and cardiovascular disorders are more prone to such conditions. Obstructive sleep apnea is the most prevalent type globally, and it necessitates early detection and treatment with sleeping aid products like drugs and devices.
What are the Advantages Offered by e-Commerce for Sleeping Aid Product Distribution?
“Enhanced Accessibility to Product Information and Discount Offerings”
| Attribute | e-Commerce |
|---|---|
| Segment Value (2024E) | US$ 6.37 Billion |
| Growth Rate (2024 to 2034) | 5.1% CAGR |
| Projected Value (2034F) | US$ 10.44 Billion |
By distribution channel, e-commerce is expected to account for 21.3% of the global market share in 2024. Through e-commerce platforms, consumers obtain all the information related to a product with its advantages and disadvantages. Also, it is an easy, comfortable, and more convenient option to purchase sleeping aids. Additionally, some e-commerce platforms offer discounts on sleeping aid products, and this reason is making it a preferred choice for budget-conscious consumers. e-Commerce platforms are also helping consumers share their personal information and giving them access to useful information.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Key players in the sleeping aid market include Pfizer Inc., Koninklijke Philips N.V., Merck & Co. Inc., Fisher & Paykel Healthcare Limited, Compumedics Ltd., Abecca Healthcare, Betterlifehealthcare Ltd., Lifeline Corporation Pte Ltd, Compumedics Ltd., and Teva Pharmaceutical Industries Ltd.
- In April 2024, Hostage Tape, a top sleeping aid manufacturer, and UFC, the top mixed martial arts organization in the world, announced a marketing agreement aimed at promoting the Hostage Tape brand across key assets of UFC.
- According to CNN Health, in April 2023, a study discovered that some of the over two dozen melatonin gummies marketed as sleeping aids in the United States had potentially harmful levels of the hormone that aids in sleep regulation.
Segmentation of Sleeping Aid Market Research
-
By Product :
- Drugs
- Insomnia Treatment Drugs
- Doxepin Hydrochloride
- Eszopiclone
- Ramelteon
- Triazolam
- Zaleplon
- Quazepam
- Narcolepsy Treatment Drugs
- Modafinil
- Sodium Oxybate
- Armodafinil
- Insomnia Treatment Drugs
- Devices
- CPAP Devices
- BiPAP Devices
- APAP Devices
- Others
- Mattresses & Pillows
- Chin Straps
- Mouth Pieces & Nasal Devices
- Drugs
-
By Indication :
- Insomnia
- Sleep Deprivation
- Narcolepsy
- Sleep Apnea
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- e-Commerce
- Drug Stores
-
By Region :
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Product USPs /Technology 4.4. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Product launches 5.2.2. Cost of Products 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as Compared to 2008 Economic analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Product 6.4.2. Revenue By Sleep Disorder 6.4.3. Revenue By Country 6.5. 2021 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected Recovery Quarter 7. Global Market Volume (Units) Analysis 2018-2023 and Forecast, 2024-2034 7.1. Historical Market Volume (Units) Analysis, 2018-2023 7.2. Current and Future Market Volume (Units) Projections, 2024-2034 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Market Value Analysis 2018-2023 and Forecast, 2024-2034 9.1. Historical Market Value (US$ Mn) Analysis, 2018-2023 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2034 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2018-2023 and Forecast 2024-2034, by Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Products & Services, 2018-2023 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2034 10.3.1. Sleep Apnea Devices 10.3.2. Medication 10.3.3. Mattresses & Pillows 10.3.4. Sleep Laboratory Services 10.4. Market Attractiveness Analysis By Product 11. Global Market Analysis 2018-2023 and Forecast 2024-2034, by Sleep Disorder 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Sleep Disorder, 2018-2023 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sleep Disorder, 2024-2034 11.3.1. Insomnia 11.3.2. Sleep Apnea 11.3.3. Restless Leg Syndrome 11.3.4. Narcolepsy 11.3.5. Sleepwalking 11.3.6. Others 11.4. Market Attractiveness Analysis By Sleep Disorder 12. Global Market Analysis 2018-2023 and Forecast 2024-2034, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2018-2023 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2034 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2018-2023 and Forecast 2024-2034 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Product 13.3.3. By Sleep Disorder 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2018-2023 and Forecast 2024-2034 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product 14.3.3. By Sleep Disorder 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2018-2023 and Forecast 2024-2034 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Product 15.3.3. By Sleep Disorder 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2018-2023 and Forecast 2024-2034 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.3.3. By Sleep Disorder 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2018-2023 and Forecast 2024-2034 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Product 17.3.3. By Sleep Disorder 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2018-2023 and Forecast 2024-2034 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By Sleep Disorder 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2034 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Product 19.3.3. By Sleep Disorder 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Market Analysis 2018-2023 and Forecast 2024-2034 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Market Analysis 20.2.1. By Product 20.2.2. By Sleep Disorder 20.3. Canada Market Analysis 20.3.1. By Product 20.3.2. By Sleep Disorder 20.4. Mexico Market Analysis 20.4.1. By Product 20.4.2. By Sleep Disorder 20.5. Brazil Market Analysis 20.5.1. By Product 20.5.2. By Sleep Disorder 20.6. U.K. Market Analysis 20.6.1. By Product 20.6.2. By Sleep Disorder 20.7. Germany Market Analysis 20.7.1. By Product 20.7.2. By Sleep Disorder 20.8. France Market Analysis 20.8.1. By Product 20.8.2. By Sleep Disorder 20.9. Italy Market Analysis 20.9.1. By Product 20.9.2. By Sleep Disorder 20.10. Spain Market Analysis 20.10.1. By Product 20.10.2. By Sleep Disorder 20.11. BENELUX Market Analysis 20.11.1. By Product 20.11.2. By Sleep Disorder 20.12. Russia Market Analysis 20.12.1. By Product 20.12.2. By Sleep Disorder 20.13. China Market Analysis 20.13.1. By Product 20.13.2. By Sleep Disorder 20.14. Japan Market Analysis 20.14.1. By Product 20.14.2. By Sleep Disorder 20.15. South Korea Market Analysis 20.15.1. By Product 20.15.2. By Sleep Disorder 20.16. India Market Analysis 20.16.1. By Product 20.16.2. By Sleep Disorder 20.17. ASEAN Market Analysis 20.17.1. By Product 20.17.2. By Sleep Disorder 20.18. Australia Market Analysis 20.18.1. By Product 20.18.2. By Sleep Disorder 20.19. New Zealand Market Analysis 20.19.1. By Product 20.19.2. By Sleep Disorder 20.20. GCC Countries Market Analysis 20.20.1. By Product 20.20.2. By Sleep Disorder 20.21. Turkey Market Analysis 20.21.1. By Product 20.21.2. By Sleep Disorder 20.22. South Africa Market Analysis 20.22.1. By Product 20.22.2. By Sleep Disorder 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Product foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. Abecca Healthcare 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. Becton, Dickinson and Company 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Profitability by Market Segments (Product/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.3. Betterlifehealthcare Ltd. 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Profitability by Market Segments (Product/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.4. Cadwell Industries, Inc. 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Profitability by Market Segments (Product/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.5. Compumedics Ltd. 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Profitability by Market Segments (Product/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.6. GlaxoSmithKline, Inc. 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Profitability by Market Segments (Product/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.7. Hill-Rom Holdings, Inc. 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Profitability by Market Segments (Product/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.8. Koninklijke Philips NV 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Profitability by Market Segments (Product/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.9. Lifeline Corporation Pte Ltd 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Profitability by Market Segments (Product/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.10. Merck & Co., Inc. 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Profitability by Market Segments (Product/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.11. Natus Medical, Inc. 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Profitability by Market Segments (Product/Channel/Region) 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.12. Pfizer, Inc. 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Profitability by Market Segments (Product/Channel/Region) 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 22.3.13. Teva Pharmaceutical Industries Ltd. 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Profitability by Market Segments (Product/Channel/Region) 22.3.13.4. Sales Footprint 22.3.13.5. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018-2034, By Product
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Product
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Sleep Disorder
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Product
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Sleep Disorder
Table 08: Latin America Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Product
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Sleep Disorder
Table 11: Europe Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Product
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Sleep Disorder
Table 14: South Asia Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Product
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Sleep Disorder
Table 17: East Asia Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Product
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Sleep Disorder
Table 20: Oceania Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Product
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Sleep Disorder
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Product
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Sleep Disorder
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2018-2023
Figure 02: Global Market Volume Forecast (in 000' Units), 2024-2034
Figure 03: Pricing Analysis (US$) Per Product, By Region, 2023
Figure 04: Pricing Analysis (US$) Per Product, By Region, 2023
Figure 05: Global Market Value Analysis (US$ Mn), 2018-2023
Figure 06: Global Market Value Forecast (US$ Mn), 2024-2034
Figure 07: Global Market Absolute $ Opportunity, 2024-2034
Figure 08: Global Market Share Analysis (%), By Product, 2024-2034
Figure 09: Global Market Y-o-Y Analysis (%), By Product, 2024-2034
Figure 10: Global Market Attractiveness Analysis by Product, 2024-2034
Figure 11: Global Market Share Analysis (%), By Sleep Disorder, 2024-2034
Figure 12: Global Market Y-o-Y Analysis (%), By Sleep Disorder, 2024-2034
Figure 13: Global Market Attractiveness Analysis by Sleep Disorder, 2024-2034
Figure 14: Global Market Share Analysis (%), By Region, 2024-2034
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2024-2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024-2034
Figure 17: North America Market Value Share, By Product, 2024 (E)
Figure 18: North America Market Value Share, By Sleep Disorder, 2024 (E)
Figure 19: North America Market Value Share, By Country, 2024 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2018-2023
Figure 21: North America Market Value Forecast (US$ Mn), 2024-2034
Figure 22: North America Market Attractiveness Analysis by Product, 2024-2034
Figure 23: North America Market Attractiveness Analysis by Sleep Disorder, 2024-2034
Figure 24: North America Market Attractiveness Analysis by Country, 2024-2034
Figure 25: Latin America Market Value Share, By Product, 2024 (E)
Figure 26: Latin America Market Value Share, By Sleep Disorder, 2024 (E)
Figure 27: Latin America Market Value Share, By Country, 2024 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2018-2023
Figure 29: Latin America Market Value Forecast (US$ Mn), 2024-2034
Figure 30: Latin America Market Attractiveness Analysis by Product, 2024-2034
Figure 31: Latin America Market Attractiveness Analysis by Sleep Disorder, 2024-2034
Figure 32: Latin America Market Attractiveness Analysis by Country, 2024-2034
Figure 33: Europe Market Value Share, By Product, 2024 (E)
Figure 34: Europe Market Value Share, By Sleep Disorder, 2024 (E)
Figure 35: Europe Market Value Share, By Country, 2024 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2018-2023
Figure 37: Europe Market Value Forecast (US$ Mn), 2024-2034
Figure 38: Europe Market Attractiveness Analysis by Product, 2024-2034
Figure 39: Europe Market Attractiveness Analysis by Sleep Disorder, 2024-2034
Figure 40: Europe Market Attractiveness Analysis by Country, 2024-2034
Figure 41: South Asia Market Value Share, By Product, 2024 (E)
Figure 42: South Asia Market Value Share, By Sleep Disorder, 2024 (E)
Figure 43: South Asia Market Value Share, By Country, 2024 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2018-2023
Figure 45: South Asia Market Value Forecast (US$ Mn), 2024-2034
Figure 46: South Asia Market Attractiveness Analysis by Product, 2024-2034
Figure 47: South Asia Market Attractiveness Analysis by Sleep Disorder, 2024-2034
Figure 48: South Asia Market Attractiveness Analysis by Country, 2024-2034
Figure 49: East Asia Market Value Share, By Product, 2024 (E)
Figure 50: East Asia Market Value Share, By Sleep Disorder, 2024 (E)
Figure 51: East Asia Market Value Share, By Country, 2024 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2018-2023
Figure 53: East Asia Market Value Forecast (US$ Mn), 2024-2034
Figure 54: East Asia Market Attractiveness Analysis by Product, 2024-2034
Figure 55: East Asia Market Attractiveness Analysis by Sleep Disorder, 2024-2034
Figure 56: East Asia Market Attractiveness Analysis by Country, 2024-2034
Figure 57: Oceania Market Value Share, By Product, 2024 (E)
Figure 58: Oceania Market Value Share, By Sleep Disorder, 2024 (E)
Figure 59: Oceania Market Value Share, By Country, 2024 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2018-2023
Figure 61: Oceania Market Value Forecast (US$ Mn), 2024-2034
Figure 62: Oceania Market Attractiveness Analysis by Product, 2024-2034
Figure 63: Oceania Market Attractiveness Analysis by Sleep Disorder, 2024-2034
Figure 64: Oceania Market Attractiveness Analysis by Country, 2024-2034
Figure 65: Middle East and Africa Market Value Share, By Product, 2024 (E)
Figure 66: Middle East and Africa Market Value Share, By Sleep Disorder, 2024 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2024 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018-2023
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2024-2034
Figure 70: Middle East and Africa Market Attractiveness Analysis by Product, 2024-2034
Figure 71: Middle East and Africa Market Attractiveness Analysis by Sleep Disorder, 2024-2034
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2024-2034
Figure 73: U. S. Market Value Analysis (US$ Mn), 2024 & 2034
Figure 74: U. S. Market Value Share, By Product, 2024 (E)
Figure 75: U. S. Market Value Share, By Sleep Disorder, 2024 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2024 & 2034
Figure 77: Canada Market Value Share, By Product, 2024 (E)
Figure 78: Canada Market Value Share, By Sleep Disorder, 2024 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2024 & 2034
Figure 80: Mexico Market Value Share, By Product, 2024 (E)
Figure 81: Mexico Market Value Share, By Sleep Disorder, 2024 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2024 & 2034
Figure 83: Brazil Market Value Share, By Product, 2024 (E)
Figure 84: Brazil Market Value Share, By Sleep Disorder, 2024 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2024 & 2034
Figure 86: U. K. Market Value Share, By Product, 2024 (E)
Figure 87: U. K. Market Value Share, By Sleep Disorder, 2024 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2024 & 2034
Figure 89: Germany Market Value Share, By Product, 2024 (E)
Figure 90: Germany Market Value Share, By Sleep Disorder, 2024 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2024 & 2034
Figure 92: France Market Value Share, By Product, 2024 (E)
Figure 93: France Market Value Share, By Sleep Disorder, 2024 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2024 & 2034
Figure 95: Italy Market Value Share, By Product, 2024 (E)
Figure 96: Italy Market Value Share, By Sleep Disorder, 2024 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2024 & 2034
Figure 98: Spain Market Value Share, By Product, 2024 (E)
Figure 99: Spain Market Value Share, By Sleep Disorder, 2024 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 101: Russia Market Value Share, By Product, 2024 (E)
Figure 102: Russia Market Value Share, By Sleep Disorder, 2024 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2024 & 2034
Figure 104: China Market Value Share, By Product, 2024 (E)
Figure 105: China Market Value Share, By Sleep Disorder, 2024 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2024 & 2034
Figure 107: Japan Market Value Share, By Product, 2024 (E)
Figure 108: Japan Market Value Share, By Sleep Disorder, 2024 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2024 & 2034
Figure 110: South Korea Market Value Share, By Product, 2024 (E)
Figure 111: South Korea Market Value Share, By Sleep Disorder, 2024 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2024 & 2034
Figure 113: India Market Value Share, By Product, 2024 (E)
Figure 114: India Market Value Share, By Sleep Disorder, 2024 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2024 & 2034
Figure 116: ASEAN Market Value Share, By Product, 2024 (E)
Figure 117: ASEAN Market Value Share, By Sleep Disorder, 2024 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 119: Australia Market Value Share, By Product, 2024 (E)
Figure 120: Australia Market Value Share, By Sleep Disorder, 2024 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2024 & 2034
Figure 122: New Zealand Market Value Share, By Product, 2024 (E)
Figure 123: New Zealand Market Value Share, By Sleep Disorder, 2024 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2024 & 2034
Figure 125: GCC Countries Market Value Share, By Product, 2024 (E)
Figure 126: GCC Countries Market Value Share, By Sleep Disorder, 2024 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2024 & 2034
Figure 128: Turkey Market Value Share, By Product, 2024 (E)
Figure 129: Turkey Market Value Share, By Sleep Disorder, 2024 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2024 & 2034
Figure 131: South Africa Market Value Share, By Product, 2024 (E)
Figure 132: South Africa Market Value Share, By Sleep Disorder, 2024 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the sleeping aid market in 2024?
The global market for sleeping aids is estimated at US$ 29.88 billion in 2024.
At what rate is the demand for sleeping aids projected to rise?
Sales of sleeping aids are forecasted to increase at 4.9% CAGR through 2034.
What is the demand projection for the global market by 2034?
The market has been forecasted to reach US$ 48.04 billion by 2034-end.
Which product type holds a significant market share of sleeping aids?
Sleeping aid drugs are projected to occupy a market share of 18.4% in 2024.
At what rate is the market forecasted to expand in Japan?
The market in Japan is projected to expand at a CAGR of 7.1% through 2034.
Who are the leading manufacturers of sleeping aids?
Key producers of sleeping aid products include Pfizer Inc., Fisher & Paykel Healthcare Limited, and Abecca Healthcare.
Sleeping Aid Market